Growth hormone reduces abdominal fat, cardiovascular risk factors in HIV patients on antiviral therapy
Thursday, July 31, 2008 - 11:21
in Health & Medicine
Low-dose growth hormone treatment reduced abdominal fat deposits and improved blood pressure and triglyceride levels in a group of patients with HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection. However, growth hormone treatment appeared to increase blood glucose levels, particularly in those already exhibiting glucose intolerance. The study from researchers at Harvard Medical School and Massachusetts General Hospital (MGH) appears in the Aug. 6 Journal of the American Medical Association, a special issue on HIV/AIDS.read more
Read the whole article on Harvard Science
More from Harvard Science
Related
- Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapySun, 3 Aug 2008, 11:35:43 EDT
- Growth hormone treatment for HIV patients improves abdominal fat, but worsens glucose levelSun, 3 Aug 2008, 11:35:41 EDT
- Hormone level may reflect mortality risk among dialysis patientsWed, 6 Aug 2008, 17:29:02 EDT
- Hormone therapy for prostate cancer does not appear to increase cardiac deathsWed, 10 Dec 2008, 12:16:00 EST
- Hormone therapy helps short children grow upThu, 6 Nov 2008, 9:17:36 EST